Your browser doesn't support javascript.
loading
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Coens, Corneel; Pe, Madeline; Dueck, Amylou C; Sloan, Jeff; Basch, Ethan; Calvert, Melanie; Campbell, Alicyn; Cleeland, Charles; Cocks, Kim; Collette, Laurence; Devlin, Nancy; Dorme, Lien; Flechtner, Hans-Henning; Gotay, Carolyn; Griebsch, Ingolf; Groenvold, Mogens; King, Madeleine; Kluetz, Paul G; Koller, Michael; Malone, Daniel C; Martinelli, Francesca; Mitchell, Sandra A; Musoro, Jammbe Z; O'Connor, Daniel; Oliver, Kathy; Piault-Louis, Elisabeth; Piccart, Martine; Quinten, Chantal; Reijneveld, Jaap C; Schürmann, Christoph; Smith, Ashley Wilder; Soltys, Katherine M; Taphoorn, Martin J B; Velikova, Galina; Bottomley, Andrew.
Afiliação
  • Coens C; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Pe M; European Organisation for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: madeline.pe@eortc.org.
  • Dueck AC; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.
  • Sloan J; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Basch E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Calvert M; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research and National Institute for Health Research Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.
  • Campbell A; Patient Relevant Evidence, San Francisco, CA, USA.
  • Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cocks K; Adelphi Values, Bollington, Cheshire, UK.
  • Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Devlin N; Centre for Health Policy, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
  • Dorme L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Flechtner HH; Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
  • Gotay C; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
  • Griebsch I; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Groenvold M; Department of Public Health, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
  • King M; School of Psychology, University of Sydney, Sydney, NSW, Australia.
  • Kluetz PG; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
  • Malone DC; College of Pharmacy, University of Arizona, Tucson, AZ, USA.
  • Martinelli F; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • Mitchell SA; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
  • Musoro JZ; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
  • O'Connor D; Medicines and Healthcare products Regulatory Agency, London, UK.
  • Oliver K; International Brain Tumour Alliance, Surrey, UK.
  • Piault-Louis E; Genentech, Roche Group, San Francisco, CA, USA.
  • Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Quinten C; European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden.
  • Reijneveld JC; Department of Neurology and Brain Tumor Center, VU University Medical Center, Amsterdam, Netherlands.
  • Schürmann C; Institute for Quality and Efficiency in Health Care, Cologne, Germany.
  • Smith AW; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
  • Soltys KM; Health Canada, Ottawa, ON, Canada.
  • Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
  • Velikova G; Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK; International Society for Quality of Life Research, Milwaukee, WI, USA.
  • Bottomley A; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Lancet Oncol ; 21(2): e83-e96, 2020 02.
Article em En | MEDLINE | ID: mdl-32007209
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Projetos de Pesquisa / Ensaios Clínicos Controlados Aleatórios como Assunto / Medidas de Resultados Relatados pelo Paciente / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Projetos de Pesquisa / Ensaios Clínicos Controlados Aleatórios como Assunto / Medidas de Resultados Relatados pelo Paciente / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article